TISEO, GIUSY
 Distribuzione geografica
Continente #
NA - Nord America 1.376
EU - Europa 651
AS - Asia 215
AF - Africa 65
SA - Sud America 9
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.322
Nazione #
US - Stati Uniti d'America 1.366
IT - Italia 217
SE - Svezia 202
SG - Singapore 96
BG - Bulgaria 73
DE - Germania 51
CI - Costa d'Avorio 44
CN - Cina 43
GB - Regno Unito 41
AT - Austria 27
IN - India 26
VN - Vietnam 26
SN - Senegal 18
CZ - Repubblica Ceca 16
HK - Hong Kong 16
CA - Canada 10
AE - Emirati Arabi Uniti 5
AU - Australia 5
BR - Brasile 5
CH - Svizzera 3
FR - Francia 3
SK - Slovacchia (Repubblica Slovacca) 3
BE - Belgio 2
CO - Colombia 2
DK - Danimarca 2
EG - Egitto 2
ES - Italia 2
IE - Irlanda 2
AR - Argentina 1
EC - Ecuador 1
EU - Europa 1
HU - Ungheria 1
JP - Giappone 1
MD - Moldavia 1
NG - Nigeria 1
NL - Olanda 1
PH - Filippine 1
PL - Polonia 1
RS - Serbia 1
RU - Federazione Russa 1
TR - Turchia 1
UA - Ucraina 1
Totale 2.322
Città #
Chandler 230
Fairfield 157
New York 77
Seattle 74
Sofia 73
Woodbridge 71
Florence 68
Ashburn 64
Wilmington 64
Houston 54
Princeton 54
Cambridge 51
Lawrence 46
Abidjan 44
Medford 35
London 29
Ogden 27
Vienna 27
Boulder 24
Singapore 24
Frankfurt am Main 21
Dakar 18
Ann Arbor 17
Hong Kong 16
Bremen 15
Pisa 15
Pune 15
Brno 14
Serra 14
San Diego 13
Stockholm 12
Kent 11
Milan 10
Rome 9
Beijing 8
Dong Ket 8
Ottawa 8
Redwood City 8
Des Moines 6
Falls Church 6
Munich 6
Castelfranci 5
Dubai 5
Hyderabad 5
Cedar Knolls 4
Hebei 4
Norwalk 4
Vicopisano 4
Bern 3
Catania 3
Los Angeles 3
Lucca 3
Sydney 3
Urgnano 3
Belo Horizonte 2
Bolzano 2
Bratislava 2
Brdo 2
Brescello 2
Brussels 2
Cairo 2
Cincinnati 2
Dublin 2
Esslingen am Neckar 2
Genoa 2
Jiaxing 2
Kilburn 2
Kolkata 2
Marina di Castagneto Carducci 2
Melbourne 2
Nanchang 2
Saint-Fons 2
Terranuova Bracciolini 2
Toronto 2
Acquasparta 1
Acton 1
Aprilia 1
Atlanta 1
Budapest 1
Buffalo 1
Capannori 1
Cascina 1
Changsha 1
Charlotte 1
Chehalis 1
Chisinau 1
Chongqing 1
Cittadella 1
Collegeville 1
Cormeilles-en-Parisis 1
Council Bluffs 1
Cutrofiano 1
Dearborn 1
Denver 1
Dordrecht 1
Duncan 1
Edinburgh 1
Gazzaniga 1
Hefei 1
Islington 1
Totale 1.658
Nome #
Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-Negative infections in ICU patients 107
Corticosteroid Use and Incident Myocardial Infarction in Adults Hospitalized for Community-acquired Pneumonia 96
C-C motive chemokine ligand 2 and thromboinflammation in COVID-19-associated pneumonia: A retrospective study 96
Impact of Initial Antifungal Therapy on the Outcome of Patients With Candidemia and Septic Shock Admitted to Medical Wards: A Propensity Score-Adjusted Analysis 86
Risk factors and outcomes of endocarditis due to non-HACEK Gram-negative bacilli: data from the prospective multicenter SEI cohort 84
Antimicrobial consumption and impact of antimicrobial stewardship programmes in long-term care facilities 84
Updates in the epidemiology and management of candidemia and Clostridioides difficile coinfection 80
Early alert from the microbiology laboratory improves the outcome of elderly patients with Enterococcus spp. bloodstream infection: Results from a multicentre prospective study 75
Identifying patients with acute bacterial skin and skin structure infection who need blood cultures 72
Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by MBL- producing Enterobacterales 58
Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae 57
Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study) 56
Predicting resistant etiology in hospitalized patients with blood cultures positive for Gram-negative bacilli 55
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality 55
Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study 52
Clinical features and outcomes of bloodstream infections caused by New Delhi metallo-β-lactamase-producing enterobacterales during a regional outbreak 51
Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes 50
Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19 50
Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients 49
Early Use of Remdesivir and Risk of Disease Progression in Hospitalized Patients With Mild to Moderate COVID-19 49
Extremely drug-resistant NDM-9-producing ST147 Klebsiella pneumoniae causing infections in Italy, May 2020 48
Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study 48
Thyroid cancer and COVID-19: experience at one single thyroid disease referral center 48
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 43
Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii 41
Elevated MICs of susceptible antipseudomonal cephalosporins in non-carbapenemase-producing, carbapenem-resistant pseudomonas aeruginosa: Implications for dose optimization 41
Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study 40
Considerations for the optimal management of antibiotic therapy in elderly patients 40
Comparison of Thrombotic Events and Mortality in Patients with Community-Acquired Pneumonia and COVID-19: A Multicenter Observational Study 40
Predictors of intensive care unit admission in patients with Legionella pneumonia: role of the time to appropriate antibiotic therapy 38
Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19 38
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients with COVID-19 Pneumonia: A Randomized Clinical Trial 37
Community-acquired Pneumonia Owing to Multidrug-Resistant Pathogens: A Step toward an Early Identification 36
Caring for older adults during the COVID-19 pandemic 36
Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: An observational study from Italy, 2020-21 34
Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern 33
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 33
Interplay between Nox2 Activity and Platelet Activation in Patients with Sepsis and Septic Shock: A Prospective Study 32
Cefiderocol for the treatment of metallo-beta-lactamases producing Gram negative bacilli: lights and shadows from the literature 32
Interpreting procalcitonin in patients undergoing hemodialysis: a reliable or a misleading marker? 29
Role of dalbavancin as combination therapy: evidence from the literature and clinical scenarios 28
Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study 27
Management of COVID patients with convalescent plasma: Do we have the final word? 26
Prevention of the spread of multidrug-resistant organisms in nursing homes 25
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 21
Characteristics of long-COVID among older adults: a cross-sectional study 18
Covid-19 early after renal transplantation: limitations and hazards of unproven therapies. Abstracts of the 20th Biennial European Society for Organ Transplantation (ESOT) Congress 18
What have we learned from the first to the second wave of COVID-19 pandemic? An international survey from the ESCMID Study Group for Infection in the Elderly (ESGIE) group 18
Characteristics of long COVID among older adults: a cross-sectional study 17
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience 14
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study) 13
Recrudescence of Plasmodium falciparum malaria 5 years after treatment in an HIV migrant: a case report with a peculiar presentation 13
Predictors and outcomes of respiratory bacterial coinfections in patients with COVID-19 admitted to hospital: An observational prospective study 13
Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM) 12
Effectiveness and safety of colistin among older adults: a systematic review and meta-analysis 9
Reply to Epling and Powers, "Cefiderocol and the Need for Higher-Quality Evidence: Methods Matter for Patients" 6
Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score 6
Totale 2.413
Categoria #
all - tutte 10.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.746


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020266 25 28 8 27 21 20 41 27 30 22 16 1
2020/2021280 10 6 5 8 10 14 71 29 38 20 35 34
2021/2022423 11 18 5 6 57 54 47 24 22 13 58 108
2022/2023878 83 97 77 81 84 111 13 69 167 2 87 7
2023/2024465 30 27 52 14 57 94 27 11 14 8 66 65
2024/202525 25 0 0 0 0 0 0 0 0 0 0 0
Totale 2.413